Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
| ▸ | HRH1 | P35367 | 3/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27902231 | 1.00 | DRD2 (0.46) | DRD2DRD3HRH1KCNH2CYP2D6 | |
| SCHEMBL28156000 | 0.81 | HRH1 (0.44) | HRH1KCNH2CYP2D6 | |
| SCHEMBL32674522 | 0.80 | RAB9A (0.46) | CYP2D6CYP3A4 | |
| SCHEMBL27932853 | 0.80 | DRD2 (0.42) | DRD2DRD3 | |
| SCHEMBL27996919 | 0.78 | DRD2 (0.49) | DRD2DRD3HRH1KCNH2CYP2D6 | |
| SCHEMBL1582896 | 0.77 | RAB9A (0.49) | CYP2D6CYP3A4 | |
| SCHEMBL22576041 | 0.77 | DRD2 (0.40) | DRD2DRD3 | |
| SCHEMBL14481220 | 0.77 | HRH1 (0.44) | DRD2DRD3HRH1KCNH2CYP2D6 | |
| SCHEMBL28657514 | 0.76 | HTT (0.45) | CYP2D6CYP3A4 | |
| SCHEMBL12609780 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108794411-A | Certain chemical entities, composition and method | 润新生物公司 | 2018-11-13 | — | — | CN | disclosed |
| CN-104053442-B | Certain chemical entities, compositions, and methods | 润新生物公司 | 2017-06-23 | — | — | CN | disclosed |
| US-20090274853-A1 | DICHROIC DYE COMPOSITION | FUJIFILM CORPORATION (JP) | 2009-11-05 | — | — | US | disclosed |
| CN-1295523-C | Optical filter | FUJI PHOTO FILM CO LTD (JP) | 2007-01-17 | — | — | CN | disclosed |
| US-6911238-B2 | Liquid crystal compositions, polarization selective membranes and liquid crystal displays | FUJI PHOTO FILM CO., LTD. (JP) | 2005-06-28 | — | — | US | disclosed |
| US-20030218715-A1 | Liquid crystal compositions, polarization selective membranes and liquid crystal displays | FUJI PHOTO FILM CO., LTD. | 2003-11-27 | — | — | US | disclosed |
| US-6586057-B1 | Filter layer contains a dye and a binder polymer. The dye is in a non-aggregated form. The dye has an absorption maximum with a half width of not more than 100 nm within the wavelength region of 560 to 620 nm. The transparent support, | FUJI PHOTO FILM CO., LTD. (JP) | 2003-07-01 | — | — | US | disclosed |
| US-6532120-B1 | Correcting color appropriately for a displayed image; absorbs undesired light component emitted from an image display (especially, a plasma display panel); a dye and a binder polymer; maximum wavelength region of 560 to 620 nm | FUJI PHOTO FILM CO., LTD. (JP) | 2003-03-11 | — | — | US | disclosed |
| CN-1331806-A | Optical filter | FUJI PHOTO FILM CO LTD (JP) | 2002-01-16 | — | — | CN | disclosed |
| EP-1124144-A1 | OPTICAL FILTER | FUJI PHOTO FILM CO., LTD. (JP) | 2001-08-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090274853-A1 | DICHROIC DYE COMPOSITION | C1S, CDY1; CDY1B, CRY1 | DRD2 247/4885DRD3 142/4885HRH1 159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.